Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer.
Weickhardt AJ, Williams DS, Lee CK, Chionh F, Simes J, Murone C, Wilson K, Parry MM, Asadi K, Scott AM, Punt CJ, Nagtegaal ID, Price TJ, Mariadason JM, Tebbutt NC.
Weickhardt AJ, et al. Among authors: chionh f.
Br J Cancer. 2015 Jun 30;113(1):37-45. doi: 10.1038/bjc.2015.209.
Br J Cancer. 2015.
PMID: 26125443
Free PMC article.
Clinical Trial.